Successful treatment of cardiogenic shock with an intra-aortic balloon pump following aluminium phosphide poisoning

  • Omid Mehrpour Atherosclerosis and Coronary Artery Research Center, Medical Toxicology and Drug Abuse Research Center (MTDRC), University of Medical Birjand University of Medical Science, Birjand Science, Birjand, Addiction Research Centre, Mashhad University of Medical Toxicology Sciences, Mashhad
  • Ahmad Amouzeshi Department of Cardiac Surgery, Birjand University of Medical Science, Birjand, Department of Cardiac Surgery, Mashhad University of Medical Science, Mashhad
  • Bita Dadpour Mashhad University of Medical Toxicology Sciences, Mashhad
  • Zohreh Oghabian Department of Clinical Toxicology, Kerman University of Medical Sciences, Kerman
  • Nasim Zamani Department of Clinical Toxicology, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran
  • Shahram Amini Department of Anesthesiology, Mashhad University of Medical Sciences, Mashhad
  • Robert S. Hoffman Department of Emergency Medicine, NYU School of Medicine, Bellevue Hospital Center, NY
Keywords: aluminium phosphide toxicity, emergency medical treatment, extracorporeal life support

Abstract

Aluminium phosphide (AlP) is a highly toxic pesticide that inhibits cytochrome oxidase c and causes oxidative stress. Death results from refractory cardiogenic shock due to myocardial dysfunction. There is very little information regarding extracorporeal life support in severe AlP poisoning. Although several therapies are available, none are curative. We report on the use of an intra-aortic balloon pump (IABP) in a 24-year-old woman presented to our hospital after an intentional ingestion of a tablet of AlP (3 g), which caused refractory AlP-induced cardiogenic shock and acute respiratory distress syndrome (ARDS). The patient underwent gastric lavage with potassium permanganate, received sodium bicarbonate intravenously, and was admitted to the intensive care unit. Echocardiography at 36 h post ingestion showed a left ventricular ejection fraction (LVEF) of <20 %. An IABP was inserted and the patient’s vital signs stabilised. After eight days, the IABP was removed and on day 20, the patient’s LVEF amounted to 50 %. IABP was successfully used and may improve future prognoses for severely poisoned AlP patients with refractory cardiogenic shock. We encourage clinical toxicologists to examine this new treatment.
Published
2014-03-15
How to Cite
1.
Mehrpour O, Amouzeshi A, Dadpour B, Oghabian Z, Zamani N, Amini S, Hoffman RS. Successful treatment of cardiogenic shock with an intra-aortic balloon pump following aluminium phosphide poisoning. Arh Hig Rada Toksikol [Internet]. 2014Mar.15 [cited 2024Apr.27];65(1). Available from: https://arhiv.imi.hr/index.php/arhiv/article/view/130
Section
Case report